<DOC>
	<DOCNO>NCT02992249</DOCNO>
	<brief_summary>This prospective uncontrolled observational study evaluate clinical outcome follow use ReCell Autologous Cell Harvesting Device ( ReCell ) adjunct closure ( re-epithelialization ) treatment life-threatening wound require graft closure , associate skin graft donor site , patient lack adequate available skin harvest conventional grafting . Treatment ReCell device may perform part single operative procedure , multiple stag procedure deem clinically necessary . Adverse event associate use ReCell device/cell suspension document . Subjects follow 1 year follow ReCell treatment .</brief_summary>
	<brief_title>Prospective Evaluation ReCellÂ® Autologous Cell Harvesting Device For Specific Compassionate Use Cases</brief_title>
	<detailed_description />
	<criteria>The patient require treatment lifethreatening wound require graft . Patient inadequate available skin harvest conventional skin grafting . The treat investigator determine 1 ) suitable alternative therapy would adequate meet patient 's medical need ; 2 ) risk associate use ReCell device great probable risk disease condition . In treat investigator 's opinion consideration severity patient 's health status , patient potential realize benefit application ReCell device . Patient hemodynamically stable . The patient ( legal representative ) able read understand instruction give inform consent . The patient active infection propose ReCell treatment site . The patient unable follow protocol . The patient know hypersensitivity trypsin Compound Sodium Lactate Irrigation ( Hartmann 's ) solution .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>